Last $108.30 USD
Change Today +0.17 / 0.16%
Volume 16.9K
BAYRY On Other Exchanges
Symbol
Exchange
Mexico
Xetra
Continuous
BrsaItaliana
As of 8:10 PM 05/20/13 All times are local (Market data is delayed by at least 15 minutes).

bayer ag-sponsored adr (BAYRY) Snapshot

Open
$108.11
Previous Close
$108.13
Day High
$108.40
Day Low
$107.57
52 Week High
05/8/13 - $109.98
52 Week Low
06/5/12 - $59.57
Market Cap
89.6B
Average Volume 10 Days
25.2K
EPS TTM
--
Shares Outstanding
826.9M
EX-Date
04/24/13
P/E TM
--
Dividend
$2.48
Dividend Yield
2.29%
Current Stock Chart for BAYER AG-SPONSORED ADR (BAYRY)

Related News

No related news articles were found.

bayer ag-sponsored adr (BAYRY) Details

Bayer Aktiengesellschaft develops, produces, and markets health care and agriculture products, and high-tech materials worldwide. The company’s HealthCare segment provides pharmaceuticals, such as prescription pharmaceuticals for the treatment of hypertension, cardiovascular and infectious diseases, cancer, multiple sclerosis, and contraception. This segment also offers consumer health products comprising over-the-counter medications, dermatology products, nutritional supplements for humans and animals, and veterinary pharmaceuticals and grooming products for livestock and companion animals. In addition, it manufactures medical care products, including blood glucose monitoring devices, such as single-strip systems and multi-strip systems; USB meters comprising integrated diabetes management software and direct plug-in to computers; systems for determining long-term blood glucose control; contrast agent injection systems for diagnostic and therapeutic medical procedures in X-ray, computed tomography, and magnetic resonance imaging; and mechanical systems for removing thrombi from blood vessels, as well as service products for its systems. Bayer Aktiengesellschaft’s CropScience segment provides insecticides, fungicides, herbicides, and seed treatment products; products in the areas of seeds and plant traits, for gardens, and the green industry; and non-agricultural pest and weed control products. The company’s MaterialScience segment offers materials in the field of polyurethanes and polycarbonates; coating and adhesive raw materials; plastics sheets and functional films; and inorganic basic chemicals, such as chlorine, sodium hydroxide solution, hydrogen, hydrochloric acid, and nitric acid. The company has a strategic alliance with OncoMed Pharmaceuticals, Inc. to develop drugs to target cancer stem cells. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

111,600 Employees
Last Reported Date: 04/25/13
Founded in 1863

bayer ag-sponsored adr (BAYRY) Top Compensated Officers

Chairman of Management Board and Chief Execut...
Total Annual Compensation: €3.0M
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €1.8M
Member of Management Board and Chief Executiv...
Total Annual Compensation: €1.5M
Head of Strategy & Human Resources, Labour Di...
Total Annual Compensation: €1.5M
Compensation as of Fiscal Year 2012.

bayer ag-sponsored adr (BAYRY) Key Developments

Bayer AG Reports Group Earnings Results for the First Quarter Ended March 31, 2013; Provides Earnings Guidance for the Year 2013

Bayer AG reported group earnings results for the first quarter ended March 31, 2013. For the quarter, the company reported sales of €10,266 million compared to €10,054 million for the same period in the last year. EBIT was €1,771 million compared to €1,631 million for the same period in the last year. EBITDA was €2,416 million compared to €2,378 million for the same period in the last year. Net income was €1,160 million or €1.40 per share compared to €1,040 million or €1.26 per share for the same period in the last year. Net cash flow advanced by 38.0% to €327 million compared to €237 million in 2012. The company provided earnings guidance for the year 2013. Group sales of approximately €41 billion targeted for 2013. The company plans to increase EBITDA before special items by a mid-single-digit percentage and core earnings per share by a high-single-digit percentage.

Bayer AG Presents at 2013 BIO International Convention, Apr-23-2013 03:45 PM

Bayer AG Presents at 2013 BIO International Convention, Apr-23-2013 03:45 PM. Venue: McCormick Place - Chicago Bulls Room, 2301 S. Lake Shore Drive, Chicago, IL 60616, United States. Speakers: Chris Seaton.

Bayer AG, Q1 2013 Earnings Call, Apr 25, 2013

Bayer AG, Q1 2013 Earnings Call, Apr 25, 2013

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAYRY:US $108.30 USD +0.17

BAYRY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $111.72 USD +0.33
Abbott Laboratories $37.81 USD +1.22
Saudi Basic Industries Corp SR92.75 SAR +0.50
Dow Chemical Co/The $35.61 USD -0.21
Unilever NV €32.81 EUR +0.055
View Industry Companies
 

Industry Analysis

BAYRY

Industry Average

Valuation BAYRY Industry Range
Price/Earnings 27.5x
Price/Sales 1.8x
Price/Book 3.6x
Price/Cash Flow 27.5x
TEV/Sales 1.5x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAYER AG-SPONSORED ADR, please visit www.bayer.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.